Tearexo

Company involved in cancer detection research

placeKobe, Hyogo, Japan calendar_todayFounded 2022 language tearexo.jp

Innovation

3 patent families — focus: Physics & computing; filing pace accelerating. Cited 17 times.

YearFilings
20231
20243

Investor mix

7 investors on record; lead investors include KUC, SBI Daigaku Hatsu Venture Ikusei Shien.

Investor typeCountShare
Venture capital343%
Private equity114%
Other / undisclosed343%
Coming soon